Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations
Journal Title: AAPS PharmSciTech - Year 2015, Vol 16, Issue 5
Abstract
The online version of this article (doi:10.1208/s12249-015-0299-8) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Yajun Liu, Gino M. Salituro, Keun-joong Lee, Annette Bak, Dennis H. Leung
Keywords
Related Articles
- EP ID EP682295
- DOI 10.1208/s12249-015-0299-8
- Views 70
- Downloads 0
Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation
Berberine hydrochloride (BH) is an isoquinolin alkaloid with promising anticancer efficacies. Nevertheless, further development and application of this compound had been hampered by its poor aqueous solubility, low gastr...
Preparation and Characterization of an Advanced Medical Device for Bone Regeneration
Tridimensional scaffolds can promote bone regeneration as a framework supporting the migration of cells from the surrounding tissue into the damaged tissue and as delivery systems for the controlled or prolonged release...
Development of a Material Sparing Bulk Density Test Comparable to a Standard USP Method for Use in Early Development of API’s
Bulk density can be a key indicator of performance, and may influence choice of formulation route of materials in pharmaceutical development. During early development, the cost of API’s can be expensive and the a...
Pediatric Suppositories of Sulpiride Solid Dispersion for Treatment of Tourette Syndrome: In Vitro and In Vivo Investigations
Pharmaceutical development was adopted in the current study to propose a pediatric rectal formulation of sulpiride as a substitute to the available oral or parenteral formulations in the management of Tourette syndrome (...
Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer
Artesunate (ART)—a well-known hydrophobic anti-malarial agent was incorporated in a polymer-lipid hybrid nanocolloidal system for anti-cancer therapeutic. The lipid negatively charged nanoemulsion was formulated...